Group One Trading’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-543,300
| Closed | -$31.9M | – | 8284 |
|
|
2023
Q4 | $31.9M | Buy |
543,300
+471,700
| +659% | +$26.5M | 0.08% | 182 |
|
|
2023
Q3 | $3.12M | Sell |
71,600
-8,300
| -10% | -$296K | 0.01% | 1279 |
|
|
2023
Q2 | $2.89M | Buy |
79,900
+30,500
| +62% | +$1.26M | 0.01% | 1390 |
|
|
2023
Q1 | $1.84M | Sell |
49,400
-71,900
| -59% | -$3.23M | 0.01% | 1605 |
|
|
2022
Q4 | $5.5M | Buy |
121,300
+73,600
| +154% | +$4.76M | 0.01% | 1082 |
|
|
2022
Q3 | $3.33M | Buy |
47,700
+9,000
| +23% | +$666K | 0.01% | 1491 |
|
|
2022
Q2 | $2.6M | Buy |
38,700
+1,700
| +5% | +$108K | ﹤0.01% | 1813 |
|
|
2022
Q1 | $3.04M | Buy |
37,000
+14,000
| +61% | +$1.43M | ﹤0.01% | 1976 |
|
|
2021
Q4 | $3.37M | Sell |
23,000
-300
| -1% | -$46.6K | ﹤0.01% | 2070 |
|
|
2021
Q3 | $4.12M | Buy |
23,300
+8,100
| +53% | +$1.3M | ﹤0.01% | 1904 |
|
|
2021
Q2 | $2.46M | Buy |
15,200
+10,400
| +217% | +$1.67M | ﹤0.01% | 2421 |
|
|
2021
Q1 | $822K | Sell |
4,800
-52,700
| -92% | -$10.4M | ﹤0.01% | 3464 |
|
|
2020
Q4 | $12.6M | Buy |
57,500
+600
| +1% | +$130K | 0.02% | 675 |
|
|
2020
Q3 | $9.45M | Buy |
56,900
+7,300
| +15% | +$999K | 0.03% | 551 |
|
|
2020
Q2 | $5.66M | Sell |
49,600
-21,500
| -30% | -$2.09M | 0.03% | 727 |
|
|
2020
Q1 | $5.46M | Buy |
71,100
+10,400
| +17% | +$933K | 0.04% | 490 |
|
|
2019
Q4 | $7.82M | Sell |
60,700
-145,600
| -71% | -$14M | 0.05% | 453 |
|
|
2019
Q3 | $16.1M | Buy |
206,300
+104,300
| +102% | +$9.79M | 0.13% | 150 |
|
|
2019
Q2 | $10.5M | Buy |
102,000
+101,000
| +10,100% | +$7.86M | 0.1% | 225 |
|
|
2019
Q1 | $73K | Buy |
+1,000
| New | +$68K | ﹤0.01% | 3373 |
|
|
2018
Q4 | – | Sell |
-13,700
| Closed | -$645K | – | 5556 |
|
|
2018
Q3 | $645K | Buy |
13,700
+10,700
| +357% | +$596K | 0.01% | 2068 |
|
|
2018
Q2 | $148K | Sell |
3,000
-6,700
| -69% | -$253K | ﹤0.01% | 3290 |
|
|
2018
Q1 | $298K | Buy |
9,700
+200
| +2% | +$5.55K | ﹤0.01% | 2467 |
|
|
2017
Q4 | $173K | Hold |
9,500
| – | – | ﹤0.01% | 3019 |
|
|
2017
Q3 | $111K | Buy |
+9,500
| New | +$55K | ﹤0.01% | 3177 |
|
|
2015
Q4 | – | Sell |
-1,000
| Closed | -$34K | – | 5192 |
|
|
2015
Q3 | $34K | Sell |
1,000
-7,300
| -88% | -$221K | ﹤0.01% | 3763 |
|
|
2015
Q2 | $261K | Buy |
+8,300
| New | +$245K | ﹤0.01% | 2342 |
|
Other funds holding MRTX
Group One Trading's MRTX Position: Q1 2024 in Review
Group One Trading sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 414,114 shares — an estimated $24.3M sold.
Group One Trading first reported a position in MRTX in Q2 2015 and held it in 17 quarters. The position peaked at $24.3M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- Group One Trading reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Group One Trading sold 414,114 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $24.3M.
- Group One Trading first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2015 and held it in 17 quarters.
- Group One Trading's Mirati Therapeutics, Inc. Common Stock position peaked at $24.3M in Q4 2023.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.